Spain Authorizes Oryzon-CETLAM VIVALDI AML Study
Oryzon says the Phase Ib pilot study will evaluate iadademstat with standard-of-care therapy in high-risk newly diagnosed AML subpopulations.
Related stories
Centurion to Resume Trading and Updates on Brothers Gold Project Option
Centurion says trading will resume and provides an update on its option to acquire the Brothers Gold Project in Suriname.
M impact | EQUITY | Nov 03, 2026, 04:30 PM UTC
Western Raises Over $55.8 Million From Private Placement
Western said it raised gross proceeds of over $55.8 million upon closing a previously announced private placement.
M impact | EQUITY | Nov 03, 2026, 04:30 PM UTC
Alphabet Plans $1.5 Billion Prepaid Energy Deal, Bloomberg Reports
Bloomberg reports that Alphabet plans a $1.5 billion prepaid energy deal arranged by Goldman.
M impact | EQUITY | Nov 03, 2026, 04:29 PM UTC
US Stocks Mixed; Nasdaq Rises About 1%
The Nasdaq rose about 1%, the S&P 500 advanced and the Dow edged lower. Technology led S&P 500 sectors, while consumer staples lagged.
M impact | EQUITY | Nov 03, 2026, 04:29 PM UTC
Fiserv Reportedly Cuts 3,000 Jobs Since June
Fiserv has reduced its workforce by 3,000 employees and contractors since June, including more than 10% of its senior management team, Reuters reports.
M impact | EQUITY | Nov 03, 2026, 04:25 PM UTC
Invenio Financial Acquires Magnolia Lane Partners’ Bankruptcy Portfolio and Investment Platform
PCA Global Ventures announced the acquisition; the transaction expands Invenio Financial’s presence in the bankruptcy asset class.
M impact | EQUITY | Nov 03, 2026, 04:24 PM UTC